Finance

David Tepper is buying what Xi Jinping is selling.

All he has to do is hack his supporters off at the knees.

We hope the dethroned crypto king really liked ‘90s rap.

Truly, the man’s self-confidence is a wonder of the world.

Walz is almost unique among national-level politicians in his relatively modest and relatively simple financial situation.

The Citadel chief wouldn’t mind drowning this CAT himself, if that’s what it takes.

Or at least companies allegedly pretending to build said robot overlords.

Although it might admit the continuing litigation has dulled a bit of the schadenfreude.

For all the talk about waiting to hear his Jackson Hole talk, folks are sure during a lot of leveraging.

While his boss is just a Florida Man with Floridian tastes.

If he wins, you can call it Elliott Airlines.

For him.

It’s pretty sure JPMorgan & co. have a bit more responsibility for all the fraud going on than the banks do, which is to say none.

Hey, it’s a start.

Recent financing news includes several companies raising money to advance their research to the clinic. Here’s a look back at funding rounds from companies such as Outpace Bio, GRO Biosciences, and Confo Therapeutics.

A new report showed that financial margins have leveled off for both hospitals and physician groups in recent months. However, costs for drugs and labor continue to climb.

And that is getting expensive.

Suffice it to say, like the bank’s purported diversity push, it did not work.

By throwing Citron Research’s Andrew Left in prison for a couple of decades.

Funny that, no?